// App-Quantinova.ai

TCT-37 : Prospective, Multi-Center Evaluation of the DESolve Nx Novolimus-Eluting Bioresorbable Coronary Scaffold: First Report of One Year Clinical and Imaging Outcomes

Researchers

Presenter

  • Alexandre Abizaid

Principal Investigators

  • Joachim Schofer

  • Michael Maeng

  • Bernhard Witzenbichler

  • Roberto Botelho

  • John A. Ormiston

  • Ricardo A. Costa

  • Jose D. Costa Jr

  • Daniel Chamie

  • Juliana P. Castro

Medical Centers

  • Cardiovascular Research Center, Sao Paulo, Brazil

  • ICU, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil

  • Triangulo Heart Institute, Uberlandia, Brazil

  • Dante Pazzanese, Sao Paulo, Brazil

  • Professor, University of Auckland Medical School, Auckland, New Zealand

  • FMABC, Sao Paulo, Brazil

  • Charite Campus Benjamin Franklin, Berlin, Germany.

  • Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp, Belgium, Antwerp, Belgium

  • Medical Care Center Prof Mathey, Prof Schofer, Hamburg University Cardiovascular Center, Hamburg, Germany

  • Aarhus University Hospital, Aarhus, Denmark

Locations

  • Brazil

  • Germany

  • United States

  • Denmark

  • Belgium

  • New Zealand

Companies

  • Elixir medical corpo

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Coronary artery lesions

  • Venous thrombosis

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved